The potential consequences of altered expression of CYP26A1, CYP26B1 and LRAT in metastatic colorectal cancer cells and their contribution to a pro-metastatic phenotype are outlined in figure 6. The gene discussed is CYP26A1; the disease is colorectal cancer.